Results 161 to 170 of about 70,315 (252)
Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis. [PDF]
Hirata Y +4 more
europepmc +1 more source
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson +13 more
wiley +1 more source
Abstract Background and aims Increased risk of alcohol dependence is recognised following bariatric surgery. Modified gastrointestinal anatomy and neurohormonal profiles lead to altered alcohol metabolism, peak blood alcohol concentrations and enhanced reward circuits and cravings.
Thomas J. Williams +4 more
wiley +1 more source
RASGRF2 as a potential pathogenic gene mediating the progression of alcoholic hepatitis to alcohol-related cirrhosis and hepatocellular carcinoma. [PDF]
Chen Z, Fan D, Hang T, Yue X.
europepmc +1 more source
Abstract Background and aims Opioid use disorder (OUD) treatment guidelines worldwide recommend opioid agonist treatment (OAT) as a long‐term, potentially indefinite treatment for managing OUD. However, many individuals express a strong interest in eventually tapering fully off treatment.
Ruyu Yan +13 more
wiley +1 more source
Non-cirrhotic Ascites: A Case of Severe Alcoholic Hepatitis. [PDF]
Ebrahim MA +4 more
europepmc +1 more source
Abstract Aims To examine the comparative effects of slow‐release oral morphine (SROM) vs. methadone for the treatment of opioid use disorder (OUD) on healthcare use. Design This retrospective cohort study emulated a target trial using electronic medical record data from Vancouver Coastal Health Authority linked with population‐based administrative ...
Vivienne Y. Zhou +5 more
wiley +1 more source
Impact of fecal microbiota transplantation in severe alcoholic hepatitis: A systematic review and meta-analysis. [PDF]
Taha AM +6 more
europepmc +1 more source
Abstract Background and aims Injection‐related bacterial infections represent a major but under‐recognised health issue among people who inject drugs (PWID). Harm reduction interventions (HRIs) like needle and syringe programmes (NSP) and opioid agonist treatment (OAT) could mitigate their burden.
Anthony Cousien +7 more
wiley +1 more source
The Leukemoid Reaction in Severe Alcoholic Hepatitis: A Case Report. [PDF]
Reddy S, Agrawal S, Kumar S, Acharya S.
europepmc +1 more source

